|
Status |
Public on Jul 10, 2012 |
Title |
GEP data from BCWM.1 cells treated with LNA antimiR-155 or scramble control |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
microRNA-155 acts as an oncogenic miRNA in B-cell lymphoproliferative disorders including Waldenstrom Macroglobulinemia (WM) and Chronic Lymphocytic Leukemia (CLL). we used an 8-mer LNA (locked nucleic acid) phosphorothioate oligonucleotide targeting the seed region of miR-155 to effectively antagonize in vitro tumor growth in WM.
|
|
|
Overall design |
We performed gene expression profiling (GEP) analysis on BCWM.1 cells after treatment with LNA antimiR-155 or scramble control for 48 hours.
|
|
|
Contributor(s) |
Zhang Y, Ghobrial IM |
Citation(s) |
22797699 |
Submission date |
Jul 09, 2012 |
Last update date |
Dec 06, 2018 |
Contact name |
Yong Zhang |
E-mail(s) |
yong_zhang@dfci.harvard.edu
|
Organization name |
Dana-Farber Cancer Institute
|
Department |
Medical Oncology
|
Street address |
450 Brookline Ave
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (1) |
GPL571 |
[HG-U133A_2] Affymetrix Human Genome U133A 2.0 Array |
|
Samples (2) |
|
Relations |
BioProject |
PRJNA170178 |